ResearcherMayo ClinicActive in the last 2 years
Megan M.L. Engels
Matched on ORCID iD 0000-0002-4708-3750; OpenAlex author ID A5008153923. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospective Multicenter Study. Co-author DOI 10.1016/j.cgh.2024.07.048↗
- Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.cgh.2024.03.038↗
- Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-control study. First author DOI 10.1007/s00261-022-03671-6↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jeanin Elise van Hooft · 3 shared papers, 2022–2025 · strength 0.54
- Paper Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.cgh.2024.03.038↗
- Paper Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-contro… DOI 10.1007/s00261-022-03671-6↗
- Paper Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospe… DOI 10.1016/j.cgh.2024.07.048↗
- Michael B. Wallace · 3 shared papers, 2022–2025 · strength 0.54
- Paper Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.cgh.2024.03.038↗
- Paper Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-contro… DOI 10.1007/s00261-022-03671-6↗
- Paper Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospe… DOI 10.1016/j.cgh.2024.07.048↗
- Candice W. Bolan · 2 shared papers, 2022–2024 · strength 0.37
- Paper Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.cgh.2024.03.038↗
- Paper Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-contro… DOI 10.1007/s00261-022-03671-6↗
- Derk C.F. Klatte · 2 shared papers, 2024–2025 · strength 0.37
- Paper Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.cgh.2024.03.038↗
- Paper Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospe… DOI 10.1016/j.cgh.2024.07.048↗
- Sanne A.M. Hoogenboom · 2 shared papers, 2022–2025 · strength 0.35
- Paper Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-contro… DOI 10.1007/s00261-022-03671-6↗
- Paper Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospe… DOI 10.1016/j.cgh.2024.07.048↗
- Yan Bi · 1 shared paper, 2024 · strength 0.20
- Monique Esther van Leerdam · 1 shared paper, 2024 · strength 0.20
- Douglas W. Mahoney · 1 shared paper, 2025 · strength 0.17
- Sonal Gandhi · 1 shared paper, 2025 · strength 0.17
- Jaime de la Fuente · 1 shared paper, 2025 · strength 0.17
- Ferga C. Gleeson · 1 shared paper, 2025 · strength 0.17
- Dhruv Sarwal · 1 shared paper, 2025 · strength 0.17
- Bhaumik S. Brahmbhatt · 1 shared paper, 2025 · strength 0.17
- Frank Lukens · 1 shared paper, 2025 · strength 0.17
- Eric J. Vargas Valls · 1 shared paper, 2025 · strength 0.17
- Shounak Majumder · 1 shared paper, 2025 · strength 0.17
- John B. Kisiel · 1 shared paper, 2025 · strength 0.17
- Vinay Chandrasekhara · 1 shared paper, 2025 · strength 0.17
- Victoria Gómez · 1 shared paper, 2025 · strength 0.17
- Massimo Raimondo · 1 shared paper, 2025 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.